Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Affordable Care Act
    • Consumer-Driven Health Care
      • Cost of Healthcare
      • COVID-19 and Public Health
      • Doctors & Hospitals
      • Public Insurance
      • Policy & Legislation
    • Direct Primary Care
    • Drug Prices & Regulations
    • Health Economics & Costs
    • Health Insurance
    • Health Reform
    • Medical Tourism
    • Medicare
    • Single-Payer/Medicare-for-All
    • Telemedicine
  • Goodman Institute
  • Contact
The Goodman Institute Health Blog

Category: Drug Prices & Regulations

Tuesday Links

Posted on January 24, 2023January 24, 2023 by John C. Goodman
  • Paragon study: In 2023, the federal government is expected to spend 6.2 percent of the economy (or more than $1.6 trillion) on mandatory health programs. The Congressional Budget Office (CBO) estimates that within 30 years, the federal government will annually spend at least 9 percent of the economy on those programs. And this is a conservative estimate.
  • A little-noticed provision of the omnibus spending bill could give the Food and Drug Administration (FDA) the power to ban off-label use of approved therapies, even though 1 in 5 prescriptions written are for an off-label use.
  • Study: Laughter really is contagious – and that’s good. (WaPo)
  • Diversity training not only doesn’t work, it may actually backfire. So why are we spending $3.4B a year on it? (NYT)
  • Fourth Quarter lobbying: almost $7 million by the American Hospital Association and $6.6 million by PhRMA. As Milton Friedman said, the question is not why we get so many bad laws; the question is, why aren’t things worse?
  • Amazon will sell generic drugs for as little as $5 a month. But, no Medicare or Medicaid or private insurance.
  • 25 of the 37 novel drugs approved in 2022, were first approved in the US.
+

The War on Drugs that Save Lives and Cure Diseases

Posted on January 24, 2023January 24, 2023 by John C. Goodman

About 85% of new medicines launched between 2012 and 2021 were available in the U.S., compared to 61% in Germany, 59% in the U.K. and 52% in France and Italy. Bluebird bio in 2021 said it was unwinding operations in Europe and withdrawing gene therapies for rare diseases, citing the challenges of “achieving appropriate value…

+

Friday Links

Posted on January 20, 2023 by John C. Goodman
  • Reason (magazine) investigation: CDC used Facebook to silence Covid dissent.
  • More than 1,000 nursing homes reached a 75% infection rate during the Covid pandemic.
  • For: more off label uses of existing drugs.
  • IRA bill is already affecting drug development – negatively.
  • What it will cost to attend this year’s Super Bowl game: almost $9,000.
  • The Manchin/Capito Trust Act would force Congress to do what it doesn’t want to do: Tackle our unfunded entitlement liabilities.
+

Thursday Links

Posted on January 19, 2023 by John C. Goodman
  • Half of all Medicare beneficiaries are now in Medicare Advantage plans.
  • Gallup: 38% say they or a family member put off medical care because of costs – the highest number in 22 years.
  • Cato: Black civil servants earned approximately 3.4 – 6.9 percentage points less because of the segregationist policies of  Woodrow Wilson – the 20th century’s most prominent “progressive.”
  • Mark Cuban’s online Cost Plus Drug Co. as 2 million customers. Cuban says the pharmacy could have saved his Dallas Mavericks basketball team $146,000. So why didn’t they?
+
  • 1
  • 2
  • 3
  • 4
  • …
  • 46
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 9 other subscribers

Popular Topics

©2023 The Goodman Institute Health Blog | Website by Lexicom